Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 8216
Gene Symbol: LZTR1
LZTR1
0.010 Biomarker group BEFREE Our study further emphasizes the involvement of the 22q11.2 region in BEEC development and highlights LZTR1 as a candidate gene underlying the urogenital malformation. 31044557 2019
Entrez Id: 4983
Gene Symbol: OPHN1
OPHN1
0.010 GeneticVariation group BEFREE These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. hypoplastic scrotum, microphallus, cryptorchidism), which had been noted to be classic features of patients with OPHN1 variants. 29960046 2019
Entrez Id: 745
Gene Symbol: MYRF
MYRF
0.010 GeneticVariation group BEFREE Heterozygous variants in MYRF should be considered in patients with variants of Scimitar syndrome and urogenital anomalies. 29446546 2018
Entrez Id: 8626
Gene Symbol: TP63
TP63
0.010 GeneticVariation group BEFREE Recurrence of split hand/foot malformation, cleft lip/palate, and severe urogenital abnormalities due to germline mosaicism for TP63 mutation. 27351625 2016
Entrez Id: 166379
Gene Symbol: BBS12
BBS12
0.010 GeneticVariation group BEFREE Comparing BBS1 versus chaperonin-like genes phenotypes we found more severe clinical features in the second group, since they displayed higher prevalence of all primary features, remarkable being the frequency of cognitive impairment (75%) in BBS12 and urogenital anomalies (83%) in patients with BBS10. 26082521 2015
Entrez Id: 582
Gene Symbol: BBS1
BBS1
0.010 Biomarker group BEFREE Comparing BBS1 versus chaperonin-like genes phenotypes we found more severe clinical features in the second group, since they displayed higher prevalence of all primary features, remarkable being the frequency of cognitive impairment (75%) in BBS12 and urogenital anomalies (83%) in patients with BBS10. 26082521 2015
Entrez Id: 79738
Gene Symbol: BBS10
BBS10
0.010 GeneticVariation group BEFREE Comparing BBS1 versus chaperonin-like genes phenotypes we found more severe clinical features in the second group, since they displayed higher prevalence of all primary features, remarkable being the frequency of cognitive impairment (75%) in BBS12 and urogenital anomalies (83%) in patients with BBS10. 26082521 2015
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
0.010 GeneticVariation group BEFREE Antley-Bixler syndrome (ABS) represents a group of heterogeneous disorders characterized by skeletal, cardiac, and urogenital abnormalities that have frequently been associated with mutations in fibroblast growth factor receptor 2 or cytochrome P450 reductase genes. 21705796 2011
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.010 GeneticVariation group BEFREE Antley-Bixler syndrome (ABS) represents a group of heterogeneous disorders characterized by skeletal, cardiac, and urogenital abnormalities that have frequently been associated with mutations in fibroblast growth factor receptor 2 or cytochrome P450 reductase genes. 21705796 2011
Entrez Id: 2624
Gene Symbol: GATA2
GATA2
0.010 Biomarker group BEFREE We serendipitously discovered an essential contribution of GATA-2 to urogenital development when the hematopoietic deficiency of Gata2 null mutant animals was complemented by a Gata2 yeast artificial chromosome (YAC) transgene; these mice died from a perinatal lethal urogenital abnormality. 18233958 2008
Entrez Id: 9839
Gene Symbol: ZEB2
ZEB2
0.010 Biomarker group BEFREE We also show that agenesis of the corpus callosum and urogenital anomalies (especially hypospadias) are significant positive predictors of a ZFHX1B defect. 16053902 2005
Entrez Id: 6928
Gene Symbol: HNF1B
HNF1B
0.010 Biomarker group BEFREE Mutations in the gene encoding the hepatocyte nuclear factor (HNF)-1beta are associated with a subtype of maturity-onset diabetes of the young (MODY 5) characterized by urogenital abnormalities. 14583183 2004
Entrez Id: 5230
Gene Symbol: PGK1
PGK1
0.010 GeneticVariation group BEFREE The human phosphoglycerate kinase (PGK1) gene is located within Xq11-Xq13, a region implicated in familial prostate carcinoma, androgen insensitivity, perineal hypospadias, and other genitourinary abnormalities. 11745195 2001
Entrez Id: 3209
Gene Symbol: HOXA13
HOXA13
0.010 GeneticVariation group BEFREE In families 1, 2, and 3, nonsense mutations truncating the encoded protein N-terminal to or within the homeodomain produce typical limb and genitourinary abnormalities; in family 4, an expansion of an N-terminal polyalanine tract produces a similar phenotype; in family 5, a missense mutation, which alters an invariant domain, produces an exceptionally severe limb phenotype; and in family 6, in which limb abnormalities were atypical, no HOXA13 mutation could be detected. 10839976 2000
Entrez Id: 2674
Gene Symbol: GFRA1
GFRA1
0.010 GeneticVariation group BEFREE Knowledge that mutations in the RET proto-oncogene cause MTC and studies documenting genitourinary abnormalities in RET or GDNF knockout mice led us to examine the GDNF/RET-GDNFR alpha signaling complex in this family. 9600247 1998
Entrez Id: 5076
Gene Symbol: PAX2
PAX2
0.010 GeneticVariation group BEFREE In this paper we have investigated the prevalence of PAX2 mutations in patients with ocular colobomas, microphthalmos, or retinal anomalies, either in isolation or with associated urogenital anomalies. 9783702 1998
Entrez Id: 5979
Gene Symbol: RET
RET
0.010 Biomarker group BEFREE Knowledge that mutations in the RET proto-oncogene cause MTC and studies documenting genitourinary abnormalities in RET or GDNF knockout mice led us to examine the GDNF/RET-GDNFR alpha signaling complex in this family. 9600247 1998
Entrez Id: 2668
Gene Symbol: GDNF
GDNF
0.010 GeneticVariation group BEFREE Knowledge that mutations in the RET proto-oncogene cause MTC and studies documenting genitourinary abnormalities in RET or GDNF knockout mice led us to examine the GDNF/RET-GDNFR alpha signaling complex in this family. 9600247 1998
Entrez Id: 51352
Gene Symbol: WT1-AS
WT1-AS
0.010 GeneticVariation group BEFREE Two Wilms tumor-aniridia-genitourinary abnormalities-mental retardation syndrome patients had total hemizygous WT1 and WIT1 deletions in both constitutional and nonsporadic type tumor cells. 8393432 1993
Entrez Id: 100528024
Gene Symbol: DEL11P13
DEL11P13
0.010 GeneticVariation group BEFREE All four del(11)(p13) cases presented with WAGR, a complex syndrome associated with a predisposition to Wilms' tumor (WT), aniridia (A), genitourinary abnormalities (G), and mental retardation (R). 2570677 1989
Entrez Id: 5080
Gene Symbol: PAX6
PAX6
0.010 GeneticVariation group BEFREE All four del(11)(p13) cases presented with WAGR, a complex syndrome associated with a predisposition to Wilms' tumor (WT), aniridia (A), genitourinary abnormalities (G), and mental retardation (R). 2570677 1989
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.010 GeneticVariation group BEFREE We have now looked for deletion or rearrangement of c-Ha-ras1 in the DNA from four subjects with del(11p13)-associated predisposition to Wilms' tumour, aniridia, genitourinary abnormalities and mental retardation. 6312328 1983
Entrez Id: 92579
Gene Symbol: G6PC3
G6PC3
0.020 Biomarker group BEFREE All patients had failure to thrive and some of the classic syndromic features of G6PC3 deficiency, including cardiac abnormalities and visibility of superficial veins in all, endocrinologic problems in PI and PIII, and urogenital abnormalities in PII. 26479985 2015
Entrez Id: 92579
Gene Symbol: G6PC3
G6PC3
0.020 Biomarker group BEFREE Glucose-6-phosphatase catalytic subunit 3 (G6PC3) deficiency is a newly described syndromic type of severe congenital neutropenia, associated with multiple organ abnormalities including facial, cardiac, and urogenital abnormalities, and increased visibility of superficial veins. 23018568 2013
Entrez Id: 546
Gene Symbol: ATRX
ATRX
0.020 GeneticVariation group BEFREE Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome. 16813605 2006